Prosecution Insights
Prosecution Insights
5 pending office actions • 3 art units • 4 examiners • 0 of 5 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 5 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 5 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 2 (40%) |
| §102 only | 1 (20%) |
| No statute on record | 2 (40%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| KIM, TAEYOON | 2 | 51.5% | +51.4% |
| NGUYEN, NGHI V | 1 | 53.6% | +50.4% |
| SHIBUYA, MARK LANCE | 1 | 32.3% | +24.9% |
| SIFFORD, JEFFREY MARK | 1 | 57.6% | +32.9% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17633063 | CELLULAR COMPOSITIONS COMPRISING VIRAL VECTORS AND METHODS OF TREATMENT | SIFFORD, JEFFREY MARK | 240d overdue |
| 18041303 | A COMPOSITION COMPRISING MESENCHYMAL PRECURSOR OR STEM CELLS AND THEIR USE | KIM, TAEYOON | 18d overdue |
| 18001462 | 3D CULTURE OF MESENCHYMAL LINEAGE PRECURSOR OR STEM CELLS | SHIBUYA, MARK LANCE | 17d overdue |
| 17906160 | METHOD FOR TREATING INFLAMMATORY BOWEL DISEASE I | KIM, TAEYOON | 6d |
| 18257515 | METHOD OF TREATING PROGRESSIVE HEART FAILURE IN SUBJECTS WITH CLASS II HEART FAILURE | NGUYEN, NGHI V | 71d |
| Art Unit | Apps |
|---|---|
| 1631 | 3 |
| 1653 | 1 |
| 1671 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18257515 | METHOD OF TREATING PROGRESSIVE HEART FAILURE IN SUBJECTS WITH CLASS II HEART FAILURE | NGUYEN, NGHI V | 1653 | §103 | Final Rejection | 71d | Pending | Jun 14, 2023 |
| 18041303 | A COMPOSITION COMPRISING MESENCHYMAL PRECURSOR OR STEM CELLS AND THEIR USE | KIM, TAEYOON | 1631 | Other | Non-Final OA | 18d overdue | Pending | Feb 10, 2023 |
| 18001462 | 3D CULTURE OF MESENCHYMAL LINEAGE PRECURSOR OR STEM CELLS | SHIBUYA, MARK LANCE | 1631 | §102 | Final Rejection | 17d overdue | Pending | Dec 09, 2022 |
| 17906160 | METHOD FOR TREATING INFLAMMATORY BOWEL DISEASE I | KIM, TAEYOON | 1631 | Other | Non-Final OA | 6d | Pending | Sep 12, 2022 |
| 17633063 | CELLULAR COMPOSITIONS COMPRISING VIRAL VECTORS AND METHODS OF TREATMENT | SIFFORD, JEFFREY MARK | 1671 | §103 | Final Rejection | 240d overdue | Pending | Feb 04, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial